Posts Tagged: Alison McGuigan
Professor Alison McGuigan (ChemE, BME) has earned an Arthur B. McDonald Fellowship from the Natural Sciences and Engineering Research Council (NSERC).
Researchers from the Institute of Biomedical Engineering at the University of Toronto have identified a novel approach to potentially slow cancer progression by targeting a key enzyme that influences cancer-associated fibroblasts (CAFs).
Professor Alison McGuigan has been honored with the prestigious Tissue Engineering and Regenerative Medicine International Society Americas Chapters (TERMIS-AM) Senior Scientist Award. This esteemed award was presented to Professor McGuigan on the final day of the 7th TERMIS World Congress Conference, held from June 25-28 in Seattle, Washington. The Senior Scientist Award is conferred upon individuals who have made significant contributions to the fields of tissue engineering and regenerative medicine.
Researchers at the University of Toronto have developed a new miniaturized assay platform, mini-MEndR, designed to evaluate muscle stem cell-mediated repair in a more efficient and scalable manner. This novel platform, funded by CFREF “Medicine by Design”, represents a significant advancement in the field of regenerative medicine, offering the potential to accelerate the discovery of therapeutic targets for muscle repair and regeneration.
New ways of growing human tissues outside the body, developed by Professor Alison McGuigan and her team, will help expand the ability of researchers to understand and control cell behaviour.
Dr. Alison McGuigan inducted as a fellow into the Canadian Academy of Engineering.
Drs. Alison McGuigan and Rodrigo Fernandez-Gonzalez received Data Science Institute Catalyst Grant, co-funded by Medicine by Design, on their work on bioimaging on cancer treatments.
Scientists out of two labs at the University of Toronto have discovered a novel way to test self-repair of skeletal muscle, and this method has the potential to rapidly advance the development of treatments for diseases like muscular dystrophy (MD) and other degenerative muscle conditions.
UHN thoracic surgeon Dr. Tom Waddell led the first session of "Regen Med in the Clinic" with University of Toronto researcher Alison McGuigan, talking to fellows about a respiratory condition from surgical and engineering perspectives.
Professor Alison McGuigan's research on predicting how well promising drugs will work in patients is making "significant progress towards one of the most difficult and important goals in biological engineering."
Showing 1 - 10 of 13 results